Skip to menu Skip to content Skip to footer

2016

Book Chapter

Interleukin-12/23 Inhibitors: Ustekinumab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). Interleukin-12/23 Inhibitors: Ustekinumab. Encyclopedia of Inflammatory Diseases. (pp. 1-3) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_232-1

Interleukin-12/23 Inhibitors: Ustekinumab

2016

Book Chapter

CD20 Inhibitors: Rituximab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). CD20 Inhibitors: Rituximab. Compendium of Inflammatory Diseases. (pp. 268-271) Springer Science+Business Media. doi: 10.1007/978-3-7643-8550-7_21

CD20 Inhibitors: Rituximab

2016

Book Chapter

Interleukin-6 Inhibitor: Tocilizumab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). Interleukin-6 Inhibitor: Tocilizumab. Compendium of Inflammatory Diseases. (pp. 692-696) Springer Science+Business Media. doi: 10.1007/978-3-7643-8550-7_231

Interleukin-6 Inhibitor: Tocilizumab

2016

Book Chapter

Tumor Necrosis Factor (TNF) Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2016). Tumor Necrosis Factor (TNF) Inhibitors. Compendium of Inflammatory Diseases. (pp. 1282-1290) Springer Science+Business Media. doi: 10.1007/978-3-7643-8550-7_67

Tumor Necrosis Factor (TNF) Inhibitors

2015

Journal Article

Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.

Seldon, T. A., Pryor, R., Palkova, A., Jones, M. L., Verma, N. D., Findova, M., Braet, K., Sheng, Y., Fan, Y., Zhou, Y. Y., Marks, J. D., Munro, T., Mahler, S. M., Barnard, R. T., Fromm, P. D., Silveira, P. A., Elgundi, Z., Ju, X., Clark, G. J., Bradstock, K. F., Munster, D. J. and Hart, D. N. J. (2015). Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.. Leukemia, 30 (3), 692-700. doi: 10.1038/leu.2015.231

Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.

2015

Journal Article

Effect of energy source, salt concentration and loading force on colloidal interactions between Acidithiobacillus ferrooxidans cells and mineral surfaces

Diao, Mengxue, Nguyen, Tuan A.H., Taran, Elena, Mahler, Stephen M. and Nguyen, Anh V. (2015). Effect of energy source, salt concentration and loading force on colloidal interactions between Acidithiobacillus ferrooxidans cells and mineral surfaces. Colloids and Surfaces B: Biointerfaces, 132, 271-280. doi: 10.1016/j.colsurfb.2015.05.026

Effect of energy source, salt concentration and loading force on colloidal interactions between Acidithiobacillus ferrooxidans cells and mineral surfaces

2015

Journal Article

Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells

Tang, Jie, Li, Li, Howard, Christopher B., Mahler, Stephen M., Huang, Leaf and Xu, Zhi Ping (2015). Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells. Journal of Materials Chemistry B, 3 (33), 6805-6812. doi: 10.1039/c5tb00912j

Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells

2015

Journal Article

Advances in drug delivery

Mahler, Stephen and Roy, Ipsita (2015). Advances in drug delivery. Journal of Chemical Technology and Biotechnology, 90 (7), 1167-1168. doi: 10.1002/jctb.4689

Advances in drug delivery

2015

Journal Article

Production and characterisation of recombinant human chaperonin 10 for treatment of inflammatory disease

Naylor, Dean J., Hunt, Ben, Guidolin, Angelo, Hey, Allan W., Bastiras, Stan, de Bakker, Christopher J., Chin, David Y., Marquis, Christopher P., Lambert, Daniel, Howard, Christopher B., Dobbin, Caroline A. and Mahler, Stephen M. (2015). Production and characterisation of recombinant human chaperonin 10 for treatment of inflammatory disease. Process Biochemistry, 50 (10) 10466, 1669-1679. doi: 10.1016/j.procbio.2015.06.022

Production and characterisation of recombinant human chaperonin 10 for treatment of inflammatory disease

2015

Book Chapter

Interleukin-6 Inhibitor – Tocilizumab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin-6 Inhibitor – Tocilizumab. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_231-1

Interleukin-6 Inhibitor – Tocilizumab

2015

Conference Publication

CD83 Expression On Human Immune Cells as a Target for Immunosuppression

Hart, D. N. J., Elgundi, Z., Ju Xinsheng, Verma, N. D., Silveira, P. A., Fromm, P. D., Alingcastre, R., Munster, D. J., Seldon, T. A., Sheng, Y., Jones, M. L., Munro, T. P., Mahler, S., Barnard, R. T., Vu, P. A., Lo, K., Shahin, K., Larsen, S., Bradstock, K. and Clark, G. J. (2015). CD83 Expression On Human Immune Cells as a Target for Immunosuppression. 33rd Annual Scientific Meeting of the Transplantation Society of Australia and new Zealand, Canberra, ACT Australia, 21-23 June 2015. London, United Kingdom: Nature Publishing Group. doi: 10.1038/icb.2015.75

CD83 Expression On Human Immune Cells as a Target for Immunosuppression

2015

Conference Publication

Characterisation of human CD83 expression on immune cells and their targeting with CD83 antibodies to prevent graft versus host disease in allogeneic haematopoietic cell transplantation

Hart, Derek N. J., Ju, Xinsheng, Elgundi, Zehra, Verma, Nirupama, Silveira, Pablo, Fromm, Phillip, Alingcastre, Renz, Hsu, Blake, Munster, David J., Seldon, Therese, Sheng, Yonghua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Al, Lo, Tsun Ho, Shahin, Kifah, Larsen, Stephen Robert, Bradstock, Kenneth and Clark, Georgina (2015). Characterisation of human CD83 expression on immune cells and their targeting with CD83 antibodies to prevent graft versus host disease in allogeneic haematopoietic cell transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL, United States, 5-8 Dec 2015. WASHINGTON: AMER SOC HEMATOLOGY.

Characterisation of human CD83 expression on immune cells and their targeting with CD83 antibodies to prevent graft versus host disease in allogeneic haematopoietic cell transplantation

2015

Conference Publication

The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent

Verma, Nirupama D., Munster, David, Seldon, Therese, Sheng, Yong Hua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Phi Ai, Lo, Kevin, Shahin, Kifah, Elgundi, Zehra, Silveira, Pablo, Fromm, Phillip D., Clark, Georgina J., Larsen, Stephen, Bradstock, Kenneth and Hart, Derek N. J. (2015). The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent. BMT Tandem Meetings, San Diego, CA United States, 11-15 February 2015. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.bbmt.2014.11.527

The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent

2015

Book Chapter

TNF Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). TNF Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-10) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_67-1

TNF Inhibitors

2015

Book Chapter

Interleukin 1 Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Interleukin 1 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-5) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_29-1

Interleukin 1 Inhibitors

2015

Book Chapter

CD20 Inhibitors: Rituximab

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD20 Inhibitors: Rituximab. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_21-1

CD20 Inhibitors: Rituximab

2015

Conference Publication

Human Cd83 Expression On Immune Cells Validates Anti-Cd83 Prophylaxis to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation.

Ju, Xinsheng, Elgundi, Zehra, Verma, Nirupama, Silveira, Pablo, Fromm, Phillip, Alingcastre, Renz, Munster, David, Seldon, Therese, Sheng, Yonghua, Jones, Martina, Munro, Trent, Mahler, Stephen, Barnard, Ross, Vu, Ai, Lo, Tsun Ho, Shahin, Kifah, Clark, Georgina, Larsen, Stephen, Bradstock, Kenneth and Hart, Derek (2015). Human Cd83 Expression On Immune Cells Validates Anti-Cd83 Prophylaxis to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation.. 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, Australia, 11-13 November 2015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Human Cd83 Expression On Immune Cells Validates Anti-Cd83 Prophylaxis to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation.

2015

Book Chapter

Disease-Modifying Anti-Rheumatic Drugs

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). Disease-Modifying Anti-Rheumatic Drugs. Encyclopedia of Inflammatory Diseases. (pp. 1-13) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_48-1

Disease-Modifying Anti-Rheumatic Drugs

2015

Book Chapter

CD80/CD86 Inhibitors

Pile, Kevin D., Graham, Garry G. and Mahler, Stephen M. (2015). CD80/CD86 Inhibitors. Encyclopedia of Inflammatory Diseases. (pp. 1-4) edited by Michael J. Parnham. Basel Switzerland: Springer. doi: 10.1007/978-3-0348-0620-6_20-1

CD80/CD86 Inhibitors

2014

Journal Article

Nanocell targeting using engineered bispecific antibodies.

Taylor, Karin, Howard, Christopher B., Jones, Martina L., Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P. and Mahler, Stephen M. (2014). Nanocell targeting using engineered bispecific antibodies.. mAbs, 7 (1), 53-65. doi: 10.4161/19420862.2014.985952

Nanocell targeting using engineered bispecific antibodies.